Cargando…
Predictors of progression from a first demyelinating event to clinically definite multiple sclerosis
Understanding the predictors of progression from a first to a second demyelinating event (and formerly, a diagnosis of clinically definite multiple sclerosis) is important clinically. Previous studies have focused on predictors within a single domain, e.g. radiological, lacking prospective data acro...
Autores principales: | Chapman, Caron, Lucas, Robyn M, Ponsonby, Anne-Louise, Taylor, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308470/ https://www.ncbi.nlm.nih.gov/pubmed/35891671 http://dx.doi.org/10.1093/braincomms/fcac181 |
Ejemplares similares
-
Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset
por: Tao, Chunrong, et al.
Publicado: (2018) -
Variation within MBP gene predicts disease course in multiple sclerosis
por: Zhou, Yuan, et al.
Publicado: (2017) -
Sun Exposure across the Life Course Significantly Modulates Early Multiple Sclerosis Clinical Course
por: Simpson, Steve, et al.
Publicado: (2018) -
Demyelination in multiple sclerosis
por: Lubetzki, Catherine, et al.
Publicado: (2014) -
Predictors of Evolution Into Multiple Sclerosis After a First Acute Demyelinating Syndrome in Children and Adolescents
por: Papetti, Laura, et al.
Publicado: (2019)